- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (316)
- Timeline of Article Publication (3)
- Authors Evaluation (2)
- Article Quality Tracking (1)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4243)
All Articles published online
|
Publishing Process of This Article
|
Mar 24, 2024 (publication date) through Aug 16, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shi JY, Che X, Wen R, Hou SJ, Xi YJ, Feng YQ, Wang LX, Liu SJ, Lv WH, Zhang YF. Ferroptosis biomarkers predict tumor mutation burden's impact on prognosis in HER2-positive breast cancer. World J Clin Oncol 2024; 15(3): 391-410 [PMID: 38576597 DOI: 10.5306/wjco.v15.i3.391] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v15/i3/391.htm |
| Number | Citing Articles |
| 1 |
Lei Yin, Yanze Lin, Zhongdian Yuan, Rexiati Ruze, Zhen Yang, Yingmei Shao. Loss of Prominin 2 expression inhibits AKT/mTOR signaling to limit glycolysis and drive ferroptosis in breast cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2025; : 120047 doi: 10.1016/j.bbamcr.2025.120047
|
| 2 |
Anqi Ge, Wang Xiang, Yan Li, Da Zhao, Junpeng Chen, Pawan Daga, Charles C. Dai, Kailin Yang, Yexing Yan, Moujia Hao, Bolin Zhang, Wei Xiao. Broadening horizons: the multifaceted role of ferroptosis in breast cancer. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1455741
|
| 3 |
Murshid Imam, Jiale Ji, Zhijie Zhang, Shunchao Yan. Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application. Frontiers in Pharmacology 2025; 15 doi: 10.3389/fphar.2024.1493188
|